Ebola Fears: Drug And Suit Makers Up In The Market

Boston, MA 10/13/2014 (wallstreetpr) – The Ebola menace is slowly finding its way in the U.S. after a nurse who cared for an Ebola patient was also diagnosed with the virus. Companies developing cures for the diseases lead by Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) and Sarepta Therapeutics Inc. (NASDAQ:SRPT) have been on an upward swing. Focus […]

Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts

Boston, MA 05/23/2014 (wallstreetpr) – Sarepta Therapeutics Inc (NASDAQ:SRPT) looks forward to a busy year in 2015 when it expects several of its experimental drugs to get the commercialization approval. In preparing for a potential big demand for its drugs, the company is scaling up capacity. It announced entering a deal to acquire a manufacturing […]

Sarepta Therapeutics Inc (NASDAQ:SRPT): Acceptance Brings Profits

Boston, MA 04/21/2014 (wallstreetpr) – Sarepta Therapeutics Inc (NASDAQ:SRPT) has experienced a drastic upheaval after the announcement that the U.S. Food and Drug Administration has accepted its new drug application. The drug is quite controversial and has been in the limelight because of the same. But all seems well, now that the company seems to be […]

Sarepta Therapeutics Inc (NASDAQ:SRPT) Plans Marketing Application For Experimental Drug By End Of 2014

Boston, MA 04/21/2014 (wallstreetpr) – Sarepta Therapeutics Inc (NASDAQ:SRPT) plans to start new trials on experimental drug after the U.S. Food and Drug Administration said that the data available could support approval.  The company is developing a drug called eteplirsen that is targeted for the treatment of Duchenne Muscle Dystrophy (DMD). The condition affects about one […]